Core Laboratories N.V.CLBNYSE
Loading
Year-over-year operating income growth rate
Percentile
P23
Within normal range
vs 5Y Ago
-0.3x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -31.00% |
| Q3 2025 | 36.86% |
| Q2 2025 | 246.19% |
| Q1 2025 | -68.84% |
| Q4 2024 | -28.42% |
| Q3 2024 | 23.71% |
| Q2 2024 | 86.77% |
| Q1 2024 | -41.22% |
| Q4 2023 | -0.62% |
| Q3 2023 | -22.40% |
| Q2 2023 | 191.71% |
| Q1 2023 | -58.50% |
| Q4 2022 | 6.64% |
| Q3 2022 | 25.69% |
| Q2 2022 | 3080.05% |
| Q1 2022 | -102.75% |
| Q4 2021 | 113.86% |
| Q3 2021 | -48.13% |
| Q2 2021 | 10.14% |
| Q1 2021 | -50.34% |
| Q4 2020 | 106.55% |
| Q3 2020 | 541.41% |
| Q2 2020 | 97.64% |
| Q1 2020 | -617.56% |
| Q4 2019 | -32.53% |
| Q3 2019 | 11.42% |
| Q2 2019 | 70.63% |
| Q1 2019 | -8.70% |
| Q4 2018 | -48.46% |
| Q3 2018 | 4.28% |
| Q2 2018 | 3.51% |
| Q1 2018 | -0.19% |
| Q4 2017 | 17.84% |
| Q3 2017 | -6.57% |
| Q2 2017 | 26.87% |
| Q1 2017 | 7.69% |
| Q4 2016 | 0.17% |
| Q3 2016 | 6.23% |
| Q2 2016 | -11.83% |
| Q1 2016 | -2.97% |